Zhao Yanglu, D'Agostino Ralph B, Malik Shaista, Watson Karol E, Bertoni Alain G, Budoff Matthew J, Cain Loretta, Correa Adolfo, Folsom Aaron R, Jacobs David R, Selvin Elizabeth, Wong Nathan D
Department of Epidemiology, University of California, Los Angeles, California, USA.
Mary and Steve Wen Cardiovascular Division, Department of Medicine, University of California-Irvine, Irvine, California, USA.
JACC Adv. 2024 Dec 13;4(1):101448. doi: 10.1016/j.jacadv.2024.101448. eCollection 2025 Jan.
There is significant heterogeneity in cardiovascular disease (CVD) risk among patients with diabetes mellitus (DM).
The purpose of this study was to develop risk scores for total CVD and its components from a contemporary pooled, observational cohort of U.S. adults with DM.
CVD-free adults with DM aged 40 to 79 years were pooled from 4 U.S. population-based cohorts (CARDIA [Coronary Artery Risk Development in Young Adults], Framingham Offspring, Jackson Heart Study, and the MESA (Multiethnic Study of Atherosclerosis) studied since 2000. Baseline DM-specific and non-DM-specific CVD risk factors were evaluated as predictors. We developed 10-year DM Risk Scores (DMRS) for total CVD, atherosclerotic CVD (ASCVD), coronary heart disease (CHD), heart failure (HF) and stroke. Score performance was validated internally and externally.
We included 2,174 adults with DM mean age 59.2 ± 10.5 years, 55.4% female and 47.5% Black followed up to 10 years. Age, sex, HbA1c, creatinine, systolic blood pressure, DM medication, and smoking were the most important predictors. The DMRS had good internal discrimination (c-statistics 0.72, 0.72, 0.72, 0.79 and 0.73 for CVD, ASCVD, CHD, HF, and stroke) and calibration (calibration slopes 0.93, 0.95, 0.93, 0.98, and 0.89 for CVD, ASCVD, CHD, HF, and stroke; Greenwood Nam-D'Agostino calibration tests were significant for CHD ( < 0.01) and CVD ( < 0.05) but not for ASCVD, HF, and stroke). From external validation in 2 other cohorts, the DMRS outperformed current risk scores.
Our U.S. pooled cohort DMRS for predicting CVD events demonstrated good predictive performance for assessing CVD risk in adults with DM.
糖尿病(DM)患者的心血管疾病(CVD)风险存在显著异质性。
本研究的目的是从美国成年糖尿病患者的当代汇总观察队列中开发总心血管疾病及其组成部分的风险评分。
从4个美国人群队列(CARDIA [年轻成年人冠状动脉风险发展研究]、弗雷明汉后代研究、杰克逊心脏研究和自2000年以来进行的MESA [动脉粥样硬化多族裔研究])中汇总年龄在40至79岁之间无心血管疾病的糖尿病成年人。将基线时特定于糖尿病和非糖尿病的心血管疾病风险因素作为预测指标进行评估。我们开发了总心血管疾病、动脉粥样硬化性心血管疾病(ASCVD)、冠心病(CHD)、心力衰竭(HF)和中风的10年糖尿病风险评分(DMRS)。对评分性能进行了内部和外部验证。
我们纳入了2174名平均年龄为59.2±10.5岁的糖尿病成年人,其中55.4%为女性,47.5%为黑人,随访长达10年。年龄、性别、糖化血红蛋白、肌酐、收缩压、糖尿病药物治疗和吸烟是最重要的预测指标。糖尿病风险评分在内部具有良好的区分度(心血管疾病、ASCVD、冠心病、心力衰竭和中风的c统计量分别为0.72、0.72、0.72、0.79和0.73)和校准度(心血管疾病、ASCVD、冠心病、心力衰竭和中风的校准斜率分别为0.93、0.95、0.93、0.98和0.89;格林伍德-南迪阿戈斯蒂诺校准测试对冠心病(<0.01)和心血管疾病(<0.05)有显著意义,但对ASCVD、心力衰竭和中风无显著意义)。在另外2个队列的外部验证中,糖尿病风险评分优于当前的风险评分。
我们用于预测心血管疾病事件的美国汇总队列糖尿病风险评分在评估糖尿病成年人的心血管疾病风险方面显示出良好的预测性能。